He Wei-Wu 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-21 4:26 pm Purchase | 2022-06-13 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 2,761,349 18.950% | 2,761,349 (New Position) | Filing |